Urgent need to accelerate UK childhood cancer diagnosis
Childhood cancer affects 400,000 children globally each year. Prompt diagnosis of childhood cancer is crucial for optimising survival and outcomes.…
Analyst Comment
ASCO 2025: Johnson & Johnson’s Akeega set to be first PARP therapy for mCSPC
ASCO 2025: DeLLphi-304 helps Amgen to pave the way for BiTEs in solid cancers
ASCO 2025: GSK’s Jemperli fails to show OS benefit in 1L advanced ovarian cancer
ASCO 2025: Corcept Therapeutics’ relacorilant emerges as promising agent in recurrent ovarian cancer
ASCO25: Focus V fails to show superiority over bevacizumab in first-line metastatic CRC
ASCO25: Trodelvy and Keytruda to become new standard of care for frontline TNBC
PureTech’s LYT-100 may expand treatment options for idiopathic pulmonary fibrosis
